Douglas R. Galasko, MD
Affiliations: | Neuroscience | University of California, San Diego, La Jolla, CA |
Area:
DementiaWebsite:
http://neurograd.ucsd.edu/faculty/detail.php?id=30Google:
"Douglas Galasko"Bio:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=73
http://ucsd.photobooks.com/directory/profile.asp?setsize=10000&dbase=main&pict_id=0001460
Cross-listing: Neurotree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Palade J, Alsop E, Courtright-Lim A, et al. (2024) Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer's Disease before Symptom Onset. Cells. 13 |
| Cousins KAQ, Irwin DJ, Tropea TF, et al. (2024) Evaluation of ATN Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease. Neurology. 102: e208033 |
| Valdes P, Henry KW, Fitzgerald MQ, et al. (2023) Limitations of the human iPSC-derived neuron model for early-onset Alzheimer's disease. Molecular Brain. 16: 75 |
| Jain L, Khrestian M, Formica S, et al. (2023) ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Blennow K, Galasko D, Perneczky R, et al. (2023) The potential clinical value of plasma biomarkers in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Shaw LM, Galasko D. (2023) Assessments of the utilities of CSF NPTX2 for disease progression in cognitively normal individuals who progress to clinical MCI and AD. Annals of Neurology |
| Gollan TH, Garcia DL, Stasenko A, et al. (2023) The MINT Sprint 2.0: A picture naming test for detection of naming impairments in Alzheimer's disease and in preclinical AD. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Sundermann EE, Campbell LM, Villers O, et al. (2023) Alzheimer's Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer's Disease Trajectory and Relationships with Cognitive Function. Viruses. 15 |
| Manca M, Standke HG, Browne DF, et al. (2023) Tau seeds occur before earliest Alzheimer's changes and are prevalent across neurodegenerative diseases. Acta Neuropathologica |
| Weiner S, Sauer M, Brinkmalm G, et al. (2023) SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |